 |
PDBsum entry 4bdq
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Metal transport
|
PDB id
|
|
|
|
4bdq
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Correlating efficacy and desensitization with gluk2 ligand-Binding domain movements.
|
 |
|
Authors
|
 |
N.Nayeem,
O.Mayans,
T.Green.
|
 |
|
Ref.
|
 |
Open Biol, 2013,
3,
130051.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
|
|
 |
 |
|
Abstract
|
 |
|
Gating of AMPA- and kainate-selective ionotropic glutamate receptors can be
defined in terms of ligand affinity, efficacy and the rate and extent of
desensitization. Crucial insights into all three elements have come from
structural studies of the ligand-binding domain (LBD). In particular,
binding-cleft closure is associated with efficacy, whereas dissociation of the
dimer formed by neighbouring LBDs is linked with desensitization. We have
explored these relationships in the kainate-selective subunit GluK2 by studying
the effects of mutating two residues (K531 and R775) that form key contacts
within the LBD dimer interface, but whose truncation unexpectedly attenuates
desensitization. One mutation (K531A) also switches the relative efficacies of
glutamate and kainate. LBD crystal structures incorporating these mutations
revealed several conformational changes that together explain their phenotypes.
K531 truncation results in new dimer contacts, consistent with slower
desensitization and sideways movement in the ligand-binding cleft correlating
with efficacy. The tested mutants also disrupted anion binding; no chloride was
detected in the dimer-interface site, including in R775A where absence of
chloride was the only structural change evident. From this, we propose that the
charge balance in the GluK2 LBD dimer interface maintains a degree of
instability, necessary for rapid and complete desensitization.
|
 |
|
|
|
|
 |